First Case in aap Implantate Study of Silver Coating Technology

aap Implantate announced that in 1Q22, first surgeries occurred as part of a human clinical trial to evaluate the company's antibacterial silver coating technology.

aap initiated the human clinical trial in late 2021 as a step toward the planned CE Mark approval of its coating technology.

In addition, aap reports that its antibacterial silver...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

  • This field is for validation purposes and should be left unchanged.

0